Tools

LEADER 02793cam 22005894a 4500

001 ocm63277820;

003 OCoLC;

005 20141211193853.0;

008 060127s2007 enka b 001 0 eng ;

010 a| 2006003075;

015 a| GBA6716312| bnb;

016 7 a| 1012662982| DNLM;

016 7 a| 0135365382| Uk;

019 a| 77540351a| 85828338;

020 a| 0195300955 (cloth : alk. paper);

020 a| 9780195300956 (cloth : alk. paper);

029 1 a| NLMb| 101266298;

029 1 a| IG#b| 0195300955;

029 1 a| YDXCPb| 2396805;

035 a| (Sirsi) o63277820;

035 a| (OCoLC)63277820;

042 a| pcc;

043 a| n-us---;

049 a| EREE;

050 00 a| HD9666.5b| .S385 2007;

060 00 a| 2006 O-238;

060 10 a| QV 736b| S413p 2007;

082 00 a| 338.4/7615109732| 22;

100 1 a| Schweitzer, Stuart O.=| ^A697482;

245 10 a| Pharmaceutical economics and policy /c| Stuart O. Schweitzer.;

250 a| 2nd ed.;

260 a| Oxford ;a| New York :b| Oxford University Press,c| 2007.;

300 a| xiv, 336 pages :b| illustrations ;c| 25 cm;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

504 a| Includes bibliographical references and index.;

505 0 a| The pharmaceutical industry -- The biotechnology industry -- Other firms in the pharmaceutical industry -- Marketing pharmaceuticals -- The demand for pharmaceuticals -- Pharmaceutical prices -- The worldwide market for pharmaceuticals -- Pricing pharmaceuticals in a world environment -- The timing of drug approvals in the United States and abroad -- Pharmaceutical regulation and cost containment by the public sector -- Regulation by the private sector -- Pharmaceutical regulation in Europe -- Patent protection -- Evaluating New Drugs -- Complementary and alternative medicines -- Pharmaceuticals and health policy : a look ahead.;

650 0 a| Pharmaceutical industryz| United States.=| ^A638;

650 0 a| Pharmaceutical policyz| United States.=| ^A139729;

650 0 a| Pharmaceutical industry.=| ^A3655;

650 12 a| Economics, Pharmaceuticalz| United States.=| ^A930695;

650 22 a| Drug Industryz| United States.=| ^A917640;

650 22 a| Public Policyz| United States.=| ^A918490;

856 41 3| Table of contents onlyu| http://www.loc.gov/catdir/toc/ecip067/2006003075.html;

856 42 3| Publisher descriptionu| http://www.loc.gov/catdir/enhancements/fy0639/2006003075-d.html;

994 a| C0b| ERE;

945 a| 1718024;

596 a| 1;

998 a| 1074915;

999 a| HD9666.5 .S385 2007w| LCc| 1i| 30372014491655d| 12/13/2010e| 9/24/2010f| 3/19/2009g| 1l| JGESm| JOYNERn| 3p| $46.20q| 1r| Ys| Yt| JGESBKu| 3/22/2007x| BOOKz| JSTACKSo| .STAFF. 0;

Pharmaceutical economics and policy / Stuart O. Schweitzer.

Author/creator	Schweitzer, Stuart O.
Format	Book
Edition	2nd ed.
Publication Info	Oxford ; New York : Oxford University Press, 2007.
Description	xiv, 336 pages : illustrations ; 25 cm
Supplemental Content	Table of contents only
Supplemental Content	Publisher description
Subjects	Pharmaceutical industry--United States. Pharmaceutical policy--United States. Pharmaceutical industry. Economics, Pharmaceutical--United States. Drug Industry--United States. Public Policy--United States.

Contents	The pharmaceutical industry -- The biotechnology industry -- Other firms in the pharmaceutical industry -- Marketing pharmaceuticals -- The demand for pharmaceuticals -- Pharmaceutical prices -- The worldwide market for pharmaceuticals -- Pricing pharmaceuticals in a world environment -- The timing of drug approvals in the United States and abroad -- Pharmaceutical regulation and cost containment by the public sector -- Regulation by the private sector -- Pharmaceutical regulation in Europe -- Patent protection -- Evaluating New Drugs -- Complementary and alternative medicines -- Pharmaceuticals and health policy : a look ahead.
Bibliography note	Includes bibliographical references and index.
LCCN	2006003075
ISBN	0195300955 (cloth : alk. paper)
ISBN	9780195300956 (cloth : alk. paper)

Availability

Library	Location	Call Number	Status	Item Actions
Joyner	General Stacks	HD9666.5 .S385 2007	✔ Available	Place Hold

Pharmaceutical economics and policy / Stuart O. Schweitzer.

Click here for more information about this title

Availability